- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the mTOR Signaling Pathway in Neuroendocrine Tumors
Authors
Keywords
Neuroendocrine tumor, Carcinoid, Pancreatic neuroendocrine tumor, mTOR inhibitor, Everolimus
Journal
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 15, Issue 3, Pages 365-379
Publisher
Springer Nature
Online
2014-08-04
DOI
10.1007/s11864-014-0294-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor
- (2013) Jennifer A. Chan et al. CANCER
- Everolimus in Advanced Pancreatic Neuroendocrine Tumors: The Clinical Experience
- (2013) J. C. Yao et al. CANCER RESEARCH
- Regulation of mTORC1 and its impact on gene expression at a glance
- (2013) M. Laplante et al. JOURNAL OF CELL SCIENCE
- Prognostic Significance of MTOR Pathway Component Expression in Neuroendocrine Tumors
- (2013) Zhi Rong Qian et al. JOURNAL OF CLINICAL ONCOLOGY
- The Genetics of Neuroendocrine Tumors
- (2013) Kjell Öberg SEMINARS IN ONCOLOGY
- Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
- (2012) H. Sorbye et al. ANNALS OF ONCOLOGY
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study
- (2012) D. Castellano et al. ONCOLOGIST
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
- (2011) Sarat Chandarlapaty et al. CANCER CELL
- Current Scientific Rationale for the Use of Somatostatin Analogs and mTOR Inhibitors in Neuroendocrine Tumor Therapy
- (2011) Corinne Bousquet et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting
- (2011) Matthew H. Kulke et al. JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus Induces Rapid Plasma Glucose Normalization in Insulinoma Patients by Effects on Tumor As Well As Normal Tissues
- (2011) H.-B. Fiebrich et al. ONCOLOGIST
- First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas
- (2010) Jonathan R. Strosberg et al. CANCER
- mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours
- (2010) A. Kasajima et al. ENDOCRINE-RELATED CANCER
- VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis
- (2010) Scott R. Silva et al. INTERNATIONAL JOURNAL OF CANCER
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Pathologic Classification of Neuroendocrine Tumors
- (2010) David S. Klimstra et al. PANCREAS
- Targeting the mTOR Signaling Network for Cancer Therapy
- (2009) Funda Meric-Bernstam et al. JOURNAL OF CLINICAL ONCOLOGY
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
- (2009) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- An Analysis of Trends and Growth Factor Receptor Expression of GI Carcinoid Tumors
- (2009) Kanika A. Bowen et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Molecular mechanisms of mTOR-mediated translational control
- (2009) Xiaoju Max Ma et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Glycemic Control in Patients with Insulinoma Treated with Everolimus
- (2009) Matthew H. Kulke et al. NEW ENGLAND JOURNAL OF MEDICINE
- O6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors
- (2008) M. H. Kulke et al. CLINICAL CANCER RESEARCH
- Molecular genetics of gastroenteropancreatic neuroendocrine tumors
- (2008) Lee F Starker et al. CURRENT OPINION IN ONCOLOGY
- Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors
- (2008) A. Moreno et al. ENDOCRINE-RELATED CANCER
- Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Pasireotide (SOM230): Development, mechanism of action and potential applications
- (2007) Herbert A. Schmid MOLECULAR AND CELLULAR ENDOCRINOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started